↓ Skip to main content

Reasons for discontinuation of subcutaneous biologic therapy in the treatment of rheumatoid arthritis: a patient perspective

Overview of attention for article published in Patient preference and adherence, January 2015
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (51st percentile)
  • Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

policy
1 policy source

Citations

dimensions_citation
63 Dimensions

Readers on

mendeley
109 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Reasons for discontinuation of subcutaneous biologic therapy in the treatment of rheumatoid arthritis: a patient perspective
Published in
Patient preference and adherence, January 2015
DOI 10.2147/ppa.s70834
Pubmed ID
Authors

Susan C Bolge, Amir Goren, Neeta Tandon

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 109 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Brazil 1 <1%
Unknown 107 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 24 22%
Student > Master 15 14%
Researcher 13 12%
Student > Bachelor 11 10%
Other 9 8%
Other 20 18%
Unknown 17 16%
Readers by discipline Count As %
Medicine and Dentistry 31 28%
Pharmacology, Toxicology and Pharmaceutical Science 12 11%
Biochemistry, Genetics and Molecular Biology 7 6%
Psychology 7 6%
Nursing and Health Professions 6 6%
Other 25 23%
Unknown 21 19%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 September 2017.
All research outputs
#8,535,684
of 25,374,917 outputs
Outputs from Patient preference and adherence
#639
of 1,757 outputs
Outputs of similar age
#110,289
of 359,530 outputs
Outputs of similar age from Patient preference and adherence
#6
of 23 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,757 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.5. This one has gotten more attention than average, scoring higher than 60% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 359,530 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.
We're also able to compare this research output to 23 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.